Decentralized Biobanking Apps for Patient Tracking of Biospecimen Research: Real-World Usability and Feasibility Study
Published version of a preprint
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Biobank privacy policies strip patient identifiers from donated specimens, undermining transparency, utility, and value for patients, scientists, and society. We are advancing decentralized biobanking apps that reconnect patients with biospecimens and facilitate engagement through a privacy-preserving nonfungible token (NFT) digital twin framework. The decentralized biobanking platform was first piloted for breast cancer biobank members. Objective: This study aimed to demonstrate the technical feasibility of (1) patient-friendly biobanking apps, (2) integration with institutional biobanks, and (3) establishing the foundation of an NFT digital twin framework for decentralized biobanking. Methods: We designed, developed, and deployed a decentralized biobanking mobile app for a feasibility pilot from 2021 to 2023 in the setting of a breast cancer biobank at a National Cancer Institute comprehensive cancer center. The Flutter app was integrated with the biobank’s laboratory information management systems via an institutional review board–approved mechanism leveraging authorized, secure devices and anonymous ID codes and complemented with a nontransferable ERC-721 NFT representing the soul-bound connection between an individual and their specimens. Biowallet NFTs were held within a custodial wallet, whereas the user experiences simulated token-gated access to personalized feedback about collection and use of individual and collective deidentified specimens. Quantified app user journeys and NFT deployment data demonstrate technical feasibility complemented with design workshop feedback. Results: The decentralized biobanking app incorporated key features: “biobank” (learn about biobanking), “biowallet” (track personal biospecimens), “labs” (follow research), and “profile” (share data and preferences). In total, 405 pilot participants downloaded the app, including 361 (89.1%) biobank members. A total of 4 central user journeys were captured. First, all app users were oriented to the ≥60,000-biospecimen collection, and 37.8% (153/405) completed research profiles, collectively enhancing annotations for 760 unused specimens. NFTs were minted for 94.6% (140/148) of app users with specimens at an average cost of US $4.51 (SD US $2.54; range US $1.84-$11.23) per token, projected to US $17,769.40 (SD US $159.52; range US $7265.62-$44,229.27) for the biobank population. In total, 89.3% (125/140) of the users successfully claimed NFTs during the pilot, thereby tracking 1812 personal specimens, including 202 (11.2%) distributed under 42 unique research protocols. Participants embraced the opportunity for direct feedback, community engagement, and potential health benefits, although user onboarding requires further refinement. Conclusions: Decentralized biobanking apps demonstrate technical feasibility for empowering patients to track donated biospecimens via integration with institutional biobank infrastructure. Our pilot reveals potential to accelerate biomedical research through patient engagement; however, further development is needed to optimize the accessibility, efficiency, and scalability of platform design and blockchain elements, as well as a robust incentive and governance structure for decentralized biobanking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional applications included monitoring changes to medical records [41], authenticated sharing of deidentified genomic and clinical cancer data [42], decentralized biobanking [43], and patient-facing access to health records and research eligibility information [44].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [43]
In the citing paper
“Nine higher-maturity studies examined applications of blockchain/DLT systems in clinical trials/research governance [36-44].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blockchain technology in healthcare: Challenges and opportunities
Attaran, M. (2022) · International Journal of Healthcare Management · doi:10.1080/20479700.2020.1843887 · Cited by 468 · cited 1×
“Although empowering patient ownership of health data is compelling in theory, full realization of such initiatives has been elusive in light of complex regulatory considerations, socioeconomic factors, and technical limitations for blockchain technologies and legacy systems [18,19].”
Deciphering the world of NFTs: A scholarly review of trends, challenges, and opportunities
Alshater, M. M., Nasrallah, N., Khoury, R., & Joshipura, M. (2025) · Electronic Commerce Research · doi:10.1007/s10660-024-09881-y · Cited by 33 · cited 1×
“One of the most promising innovations enabled by blockchains are nonfungible tokens (NFTs), digital record identifiers that serve as electronic deeds for provably unique digital or physical assets that may be represented “on-chain” [15].”
Research works printed but not linked: 43
- 10.1089/bio.2018.0054 · DOI
- 10.1186/s13167-016-0053-7 · DOI · Paper page
- 10.1089/bio.2018.0099 · DOI
- 10.1093/bfgp/elx008 · DOI
- 10.1186/s40504-014-0020-9 · DOI
- 10.1016/j.ajpath.2020.01.014 · DOI
- 10.1089/gtmb.2016.0395 · DOI
- 10.1038/gim.2012.162 · doi:10.1038/gim.2012.162
- 10.1038/nm0313-253a · DOI
- 10.2196/28496 · DOI
- 10.2196/20713 · DOI
- Bayyapu, S, 2020, Int J Adv Res Eng Technol, 11, 2748
- 10.1080/15265161.2023.2256286 · doi:10.1080/15265161.2023.2256286
- 10.1038/s41431-019-0560-9 · DOI
- 10.1016/j.jnca.2019.02.027 · DOI · Paper page
- 10.20955/r.103.153-74 · DOI · Paper page
- 10.1016/j.jbvi.2019.e00151 · DOI · Paper page
- 10.30953/bhty.v7.303 · DOI
- 10.2196/59485 · DOI
- 10.1038/s41598-024-75708-3 · doi:10.1038/s41598-024-75708-3
- 10.1089/bio.2020.0057 · DOI
- 10.1089/bio.2024.0131 · doi:10.1089/bio.2024.0131
- 10.2196/29905 · DOI
- 10.1097/ANS.0000000000000435 · DOI
- 10.1353/hpu.0.0323 · DOI · Paper page
- 10.1111/j.1752-8062.2008.00108.x · doi:10.1111/j.1752-8062.2008.00108.x
- 10.1089/bio.2020.0144 · doi:10.1089/bio.2020.0144
- 10.21203/rs.3.rs-3816689/v1 · doi:10.21203/rs.3.rs-3816689/v1
- 10.1093/jamia/ocac197 · DOI
- 10.2147/bsam.s100899 · DOI
- 10.1089/bio.2015.0089 · DOI
- 10.1089/bio.2014.1251 · DOI
- 10.1007/s11948-021-00311-y · DOI
- Sabharwal, K, 2025, J Health Care Law Policy
- 10.1080/23294515.2020.1851313 · DOI
- 10.2196/59485 · DOI
- 10.2196/17199 · DOI
- 10.1089/bio.2016.0092 · DOI
- 10.1093/jncimonographs/lgr010 · doi:10.1093/jncimonographs/lgr010
- 10.1177/1355819615599014 · DOI
- 10.1080/15265161.2025.2470695 · doi:10.1080/15265161.2025.2470695
- 10.1158/1940-6207.CAPR-22-0034 · doi:10.1158/1940-6207.capr-22-0034
- 10.4108/icst.pervasivehealth.2011.246027 · DOI
Cited by
Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review
Yaghobian, S., Sulkowski, N., Galambos, G., Scarazzini, L., Maloumian, N., & Verhaeghe, S. (2026) · Journal of Medical Internet Research · doi:10.2196/96098 · Cited by 1
Metadata
- Authors
- Sanchez, W., Dewan, A., Budd, E., Eifler, M., Miller, R. C., Kahn, J., Macis, M., & Gross, M.
- ORCID
- Venue
- JMIR Bioinformatics and Biotechnology
- Publisher
- JMIR Publications Inc.
- Published
- 2025-04-10
- Volume
- 6
- Pages
- e70463
- ISSN
- 2563-3570
- Cited by
- 9
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decentralized Biobanking Apps for Patient Tracking of Biospecimen Research: Real-World Usability and Feasibility Study. https://app.cochat.ai/papers/10.2196/70463
- The paper
- Sanchez, W., Dewan, A., Budd, E., Eifler, M., Miller, R. C., Kahn, J., Macis, M., & Gross, M. (2025). Decentralized Biobanking Apps for Patient Tracking of Biospecimen Research: Real-World Usability and Feasibility Study. JMIR Bioinformatics and Biotechnology. https://doi.org/10.2196/70463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.